Limited Exclusion Notification. THIS IS TO NOTIFY you in accordance with Section 2872 of the California Labor Code that the foregoing Agreement between you and Company does not require you to assign or offer to assign to Company any Invention that you develop entirely on your own time without using Company’s equipment, supplies, facilities or trade secret information, except for those Inventions that either: a. Relate at the time of conception or reduction to practice to Company’s business, or actual or demonstrably anticipated research or development; or b. Result from any work performed by you for Company. To the extent a provision in the foregoing Agreement purports to require you to assign an Invention otherwise excluded from the preceding paragraph, the provision is against the public policy of this state and is unenforceable. This limited exclusion does not apply to any patent or Invention covered by a contract between Company and the United States or any of its agencies requiring full title to such patent or Invention to be in the United States. [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. XXXXXXX X [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. THIS INDEMNITY AGREEMENT (this “Agreement”) dated as of this 4th day of February, 2010, is made by and between ONYX PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and XXX X. LOVE, M.D. (“Indemnitee”).
Appears in 1 contract
Samples: Transition and Retirement Agreement (Onyx Pharmaceuticals Inc)
Limited Exclusion Notification. THIS IS TO NOTIFY you in accordance with Section 2872 of the California Labor Code that the foregoing Agreement between you and Company does not require you to assign or offer to assign to Company any Invention that you develop entirely on your own time without using Company’s equipment, supplies, facilities or trade secret information, except for those Inventions that either:
a. Relate at the time of conception or reduction to practice to Company’s business, or actual or demonstrably anticipated research or development; or
b. Result from any work performed by you for Company. To the extent a provision in the foregoing Agreement purports to require you to assign an Invention otherwise excluded from the preceding paragraph, the provision is against the public policy of this state and is unenforceable. This limited exclusion does not apply to any patent or Invention covered by a contract between Company and the United States or any of its agencies requiring full title to such patent or Invention to be in the United States. [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. XXXXXXX X XXXXXXXXX XXXXXXXXX [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. INDEMNITY AGREEMENT THIS INDEMNITY AGREEMENT (this “Agreement”) dated as of this 4th day of February, 2010, is made by and between ONYX PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and XXX X. LOVE, M.D. (“Indemnitee”).
Appears in 1 contract
Samples: Transition and Retirement Agreement
Limited Exclusion Notification. THIS IS TO NOTIFY you in accordance with Section 2872 of the California Labor Code that the foregoing Agreement between you and Company does not require you to assign or offer to assign to Company any Invention that you develop entirely on your own time without using Company’s 's equipment, supplies, facilities or trade secret information, except for those Inventions that either:
a. Relate at the time of conception or reduction to practice to Company’s 's business, or actual or demonstrably anticipated research or development; or;
b. Result from any work performed by you for Company. To the extent a provision in the foregoing Agreement purports to require you to assign an Invention otherwise excluded from the preceding paragraph, the provision is against the public policy of this state and is unenforceable. This limited exclusion does not apply to any patent or Invention invention covered by a contract between Company and the United States or any of its agencies requiring full title to such patent or Invention to be in the United States. [ * ] = Certain confidential information contained in this documentIn exchange for the severance benefits to be provided to me by Pacific Ethanol, marked by bracketsInc. (the "Company") pursuant to the terms of my Employment Agreement (the "Agreement"), has been omitted and filed separately I hereby provide the following General Release of Claims (the "Release"). I understand that, on the last date of my employment with the Securities Company, the Company will pay me any accrued salary to which I am entitled by law, regardless of whether I sign this Release, but I am not entitled to any severance benefits unless I sign and Exchange Commission pursuant return this Release to Rule 24b-2 the Company and I allow it to become effective. I hereby generally and completely release the Company and its directors, officers, employees, shareholders, partners, agents, attorneys, predecessors, successors, parent and subsidiary entities, insurers, affiliates, and assigns (collectively the "Released Parties") of and from any and all claims, liabilities and obligations, both known and unknown, arising out of or in any way related to events, acts, conduct, or omissions occurring at any time prior to or at the Securities Exchange Act time that I sign this Release. This general release includes, but is not limited to: (1) all claims arising out of 1934, as amended. XXXXXXX X [ * ] = Certain confidential information contained or in this document, marked by brackets, has been omitted and filed separately any way related to my employment with the Securities and Exchange Commission pursuant to Rule 24b-2 Company or the termination of the Securities Exchange Act of 1934, as amended. THIS INDEMNITY AGREEMENT (this “Agreement”) dated as of this 4th day of February, 2010, is made by and between ONYX PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and XXX X. LOVE, M.D. (“Indemnitee”).that employment;
Appears in 1 contract
Limited Exclusion Notification. NOTICE TO NORTH CAROLINA, DELAWARE, ILLINOIS, AND KANSAS RESIDENTS: THIS IS TO NOTIFY you in accordance with North Carolina General Statute Sections 66.57.1 and 66.57.2; Delaware Code Title 19 Section 2872 of the California Labor Code 805; Illinois 765ILCS1060/1-3, “Employees Patent Act”; and Kansas Statutes Section 44-130, that the foregoing Agreement between you and the Company does not require you to assign or offer to assign to the Company any Invention invention that you develop developed entirely on your own time without using the Company’s equipment, supplies, facilities or trade secret information, information except for those Inventions inventions that either:
a. Relate at the time of conception or reduction to practice of the invention to the Company’s business, or actual or demonstrably anticipated research or developmentdevelopment of the Company; or
b. Result from any work performed by you for the Company. To the extent a provision in the foregoing Agreement purports to require you to assign an Invention invention otherwise excluded from the preceding paragraph, the provision is against the public policy of this state and is unenforceable. You shall have the burden of establishing that any invention is excluded from assignment to the Company by the preceding paragraph. This limited exclusion does not apply to any patent or Invention invention covered by a contract between the Company and the United States or any of its agencies requiring full title to such patent or Invention invention to be in the United States. [ * ] = Certain confidential information contained NOTICE TO MINNESOTA RESIDENTS: Notification is hereby given pursuant to Minnesota Statutes 13A Section 181.87 that no provision in this documentAgreement requires you to assign any of your rights to an invention for which no equipment, marked supplies, facility, or trade secret information of the Company was used and which was developed entirely on your own time, and (a) which does not relate (i) directly to the business of the Company, or (ii) to the Company’s actual or demonstrably anticipated research or development, or (b) which does not result from any work performed by brackets, has been omitted and filed separately with you for the Securities and Exchange Commission Company. NOTICE TO WASHINGTON RESIDENTS: Notification is hereby given pursuant to Rule 24b-2 of the Securities Exchange Act of 1934Washington Revised Code, as amended. XXXXXXX X [ * ] = Certain confidential information contained Title 49 RCW: Labor Regulations Chapter 49.44.140, that no provision in this documentAgreement applies to an Invention for which no equipment, marked supplies, facility, or trade secret information of Company was used and which was developed entirely on your own time, unless (a) the invention relates (i) directly to the business of Company or (ii) to Company’s actual or demonstratively anticipated research or development, or (b) the invention results from any work performed by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. THIS INDEMNITY AGREEMENT (this “Agreement”) dated as of this 4th day of February, 2010, is made by and between ONYX PHARMACEUTICALS, INCyou for Company., a Delaware corporation (the “Company”), and XXX X. LOVE, M.D. (“Indemnitee”).
Appears in 1 contract
Limited Exclusion Notification. NOTICE TO NORTH CAROLINA, DELAWARE, ILLINOIS, AND KANSAS RESIDENTS: THIS IS TO NOTIFY you in accordance with North Carolina General Statute Sections 66.57.1 and 66.57.2; Delaware Code Title 19 Section 2872 of the California Labor Code 805; Illinois 765ILCS1060/1-3, “Employees Patent Act”; and Kansas Statutes Section 44-130, that the foregoing Agreement between you and the Company does not require you to assign or offer to assign to the Company any Invention invention that you develop developed entirely on your own time without using the Company’s equipment, supplies, facilities or trade secret information, information except for those Inventions inventions that either:
a. Relate at the time of conception or reduction to practice of the invention to the Company’s business, or actual or demonstrably anticipated research or developmentdevelopment of the Company; or
b. Result from any work performed by you for the Company. To the extent a provision in the foregoing Agreement purports to require you to assign an Invention invention otherwise excluded from the preceding paragraph, the provision is against the public policy of this state and is unenforceable. You shall have the burden of establishing that any invention is excluded from assignment to the Company by the preceding paragraph. This limited exclusion does not apply to any patent or Invention invention covered by a contract between the Company and the United States or any of its agencies requiring full title to such patent or Invention invention to be in the United States. [ * ] = Certain confidential information contained NOTICE TO MINNESOTA RESIDENTS: Notification is hereby given pursuant to Minnesota Statutes 13A Section 181.87 that no provision in this documentAgreement requires you to assign any of your rights to an invention for which no equipment, marked supplies, facility, or trade secret information of the Company was used and which was developed entirely on your own time, and (a) which does not relate (i) directly to the business of the Company, or (ii) to the Company’s actual or demonstrably anticipated research or development, or (b) which does not result from any work performed by brackets, has been omitted and filed separately with you for the Securities and Exchange Commission Company. NOTICE TO WASHINGTON RESIDENTS: Notification is hereby given pursuant to Rule 24b-2 of the Securities Exchange Act of 1934Washington Revised Code, as amended. XXXXXXX X [ * ] = Certain confidential information contained Title 49 RCW: Labor Regulations Chapter 49.44.140, that no provision in this documentAgreement applies to an Invention for which no equipment, marked supplies, facility, or trade secret information of Company was used and which was developed entirely on your own time, unless (a) the invention relates (i) directly to the business of Company, or (ii) to Company’s actual or demonstratively anticipated research or development, or (b) the invention results from any work performed by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. THIS INDEMNITY AGREEMENT (this “Agreement”) dated as of this 4th day of February, 2010, is made by and between ONYX PHARMACEUTICALS, INCyou for Company., a Delaware corporation (the “Company”), and XXX X. LOVE, M.D. (“Indemnitee”).
Appears in 1 contract
